Home › Asset managers › Compare 2024-2025 › Dimensional vs Charles Schwab
Dimensional 2024-2025 · Charles Schwab 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 14,864 | 13,561 | 1,206 | 97 | 91.8% | 91.8% |
| Board proposals | 13,889 | 12,724 | 1,135 | 30 | 91.8% | 91.8% |
| E&S shareholder proposals | 232 | 165 | 1 | 66 | 99.4% | 93.1% |
| Other items | 743 | 672 | 70 | 1 | 90.6% | 90.6% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
1,303 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Dimensional | Charles Schwab |
|---|---|---|---|---|---|---|
| HUDSON PACIFIC PROPERTIES INC. | May 14, 2025 | The approval of the Amended and Restated 2010 Incentive Award Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 9 funds |
| HUNTINGTON BANCSHARES INC. | April 16, 2025 | An advisory resolution to approve, on a non-binding basis, the compensation of executives as disclosed in the accompanying proxy statement. Say-on-Pay |
Board | For | AGAINST 19 funds |
FOR 16 funds |
| HYLIION HOLDINGS CORP. | May 20, 2025 | To approve, on an advisory basis, compensation for the Company's named executive officers, as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 11 funds |
FOR 5 funds |
| ICHOR HOLDINGS LTD. | May 14, 2025 | To approve the adoption of the Ichor Holdings, Ltd. 2025 Omnibus Incentive Plan. Compensation |
Board | For | AGAINST 21 funds |
FOR 7 funds |
| IDEAL POWER INC. | June 12, 2025 | Approval, on a non-binding, advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| IDENTIV INC. | June 10, 2025 | Election of Directors: Laura Angelini Director Elections |
Board | For | WITHHOLD 4 funds |
FOR 1 fund |
| IDENTIV INC. | June 10, 2025 | To approve the compensation of the Company's named executive officers, on a non-binding advisory basis; and Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 2 funds |
| IDT CORP. | December 12, 2024 | Election of Directors: Elaine S. Yatzkan Director Elections |
Board | For | AGAINST 15 funds |
FOR 4 funds |
| IDT CORP. | December 12, 2024 | Election of Directors: Howard S. Jonas Director Elections |
Board | For | AGAINST 15 funds |
FOR 4 funds |
| ILLUMINA INC. | May 21, 2025 | Election of Directors: Robert S. Epstein, M.D. Director Elections |
Board | For | FOR 10 funds |
AGAINST 11 funds |
| INCYTE CORP. | June 10, 2025 | Approve amendments of the Company's Amended and Restated 2010 Stock Incentive Plan. Compensation |
Board | For | AGAINST 3 funds |
FOR 15 funds |
| INCYTE CORP. | June 10, 2025 | Election of Directors: Jean-Jacques Bienaime Director Elections |
Board | For | AGAINST 3 funds |
FOR 15 funds |
| INDIE SEMICONDUCTOR INC. | June 4, 2025 | To approve an amendment to the 2021 Omnibus Equity Incentive Plan to increase the number of shares of Class A Common Stock reserved for issuance thereunder by 17,000,000 shares. Compensation |
Board | For | AGAINST 8 funds |
FOR 4 funds |
| INDIE SEMICONDUCTOR INC. | June 4, 2025 | To elect three Class I directors for terms expiring at the 2028 Annual Meeting of Stockholders: Ichiro Aoki Director Elections |
Board | For | WITHHOLD 8 funds |
FOR 4 funds |
| INFORMATIC | June 18, 2025 | Advisory vote on the compensation of our named executive officers. Say-on-Pay |
Board | Not determined | AGAINST 1 fund |
FOR 9 funds |
| INFORMATION SERVICES GROUP INC. | April 24, 2025 | To approve, in a non-binding advisory vote, the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 17 funds |
FOR 3 funds |
| INGERSOLL | June 12, 2025 | Election of Directors: William P. Donnelly Director Elections |
Board | Not determined | AGAINST 3 funds |
FOR 13 funds |
| INGLES MARKETS INC. | March 3, 2025 | To approve, by non-binding vote, executive compensation, as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 22 funds |
FOR 8 funds |
| INMUNE BIO INC. | June 10, 2025 | To approve the Second Amended and Restated INmune Bio Inc. 2021 Stock Incentive Plan. Compensation |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| INNOVATIVE INDUSTRIAL PROPERTIES INC. | June 11, 2025 | Approval on a non-binding advisory basis of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 12 funds |
| INNOVEX INTERNATIONAL INC. | May 14, 2025 | To adopt the Company's 2025 Long-Term Incentive Plan. Compensation |
Board | For | AGAINST 19 funds |
FOR 7 funds |
| INNOVIVA INC. | May 19, 2025 | Elect five directors to serve until the 2026 Annual Meeting of Stockholders: Mark A. DiPaolo, Esq. Director Elections |
Board | For | FOR 19 funds |
AGAINST 7 funds |
| INOGEN INC. | May 14, 2025 | To approve the Inogen, Inc. Amended and Restated 2023 Equity Incentive Plan. Compensation |
Board | For | FOR 14 funds |
AGAINST 2 funds |
| INOGEN INC. | May 14, 2025 | To approve, on an advisory and non-binding basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 15 funds |
FOR 3 funds |
| INOVIO PHARMACEUTICALS INC. | May 20, 2025 | To approve, on a non-binding advisory basis, the resolution regarding compensation of our named executive officers described in the accompanying proxy statement. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 3 funds |
| INSIGHT EN | May 13, 2025 | Election of Directors: Catherine Courage Director Elections |
Board | Not determined | FOR 20 funds |
AGAINST 10 funds |
| INTEL CORP. | May 6, 2025 | Advisory vote on executive compensation (Say-On-Pay). Say-on-Pay |
Board | For | AGAINST 17 funds |
FOR 13 funds |
| INTEL CORP. | May 6, 2025 | Approval of amendment and restatement of the 2006 Equity Incentive Plan. Compensation |
Board | For | AGAINST 16 funds |
FOR 12 funds |
| INTERACTIVE BROKERS GROUP INC. | April 17, 2025 | Election of Directors: Paul J. Brody Director Elections |
Board | For | AGAINST 10 funds |
FOR 14 funds |
| INTERACTIVE BROKERS GROUP INC. | April 17, 2025 | To approve, by non-binding vote, executive compensation. Say-on-Pay |
Board | For | AGAINST 11 funds |
FOR 17 funds |
| INTERDIGITAL INC. | June 11, 2025 | Election of Directors: Joan H. Gillman Director Elections |
Board | For | AGAINST 2 funds |
FOR 7 funds |
| INTERNATIONAL FLAVORS & FRAGRANCES INC. | May 1, 2025 | Approve, on an advisory basis, the compensation of our named executive officers in 2024. Say-on-Pay |
Board | For | AGAINST 18 funds |
FOR 15 funds |
| INTERPUBLIC GROUP OF COMPANIES INC. | March 18, 2025 | IPG Compensation Proposal. Proposal to approve, on a non-binding, advisory basis, certain compensation that may be paid or become payable to IPG's named executive officers that is based on or otherwise relates to the merger; and Say-on-Pay |
Board | For | AGAINST 23 funds |
FOR 17 funds |
| INTRA-CELLULAR THERAPIES INC. | March 27, 2025 | To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to ITI's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 11 funds |
| INTUIT INC. | January 23, 2025 | Election of Directors: Raul Vazquez Director Elections |
Board | For | AGAINST 12 funds |
FOR 13 funds |
| INTUITIVE SURGICAL INC. | May 1, 2025 | The amendment and restatement of the Amended and Restated 2010 Incentive Award Plan. Compensation |
Board | For | FOR 11 funds |
AGAINST 15 funds |
| IOVANCE BIOTHERAPEUTICS INC. | June 10, 2025 | To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Athena Countouriotis, M.D. Director Elections |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| IOVANCE BIOTHERAPEUTICS INC. | June 10, 2025 | To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Michael Weiser, M.D., Ph.D. Director Elections |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| IOVANCE BIOTHERAPEUTICS INC. | June 10, 2025 | To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Ryan Maynard Director Elections |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| IOVANCE BIOTHERAPEUTICS INC. | June 10, 2025 | To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Wayne P. Rothbaum Director Elections |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| IQVIA HOLDINGS INC. | April 24, 2025 | Approve an advisory (non-binding) resolution to approve IQVIA's executive compensation (say-on-pay). Say-on-Pay |
Board | For | AGAINST 22 funds |
FOR 16 funds |
| IROBOT CORP. | May 16, 2025 | Approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 13 funds |
FOR 8 funds |
| IROBOT CORP. | May 16, 2025 | Elect two (2) Class II directors, nominated by the board of directors, each to serve for a three-year term, and until his successor has been duly elected and qualified or until his earlier death, resignation or removal: Neal Goldman Director Elections |
Board | For | AGAINST 12 funds |
FOR 7 funds |
| IRONWOOD PHARMACEUTICALS INC. | June 10, 2025 | Approval, by non-binding advisory vote, of the compensation paid to the named executive officers. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 8 funds |
| ITT INC. | May 21, 2025 | Approval of a non-binding advisory vote on executive compensation Say-on-Pay |
Board | For | AGAINST 16 funds |
FOR 15 funds |
| IVANHOE ELECTRIC INC. | June 5, 2025 | Election of Directors: Priya Patil Director Elections |
Board | For | FOR 3 funds |
AGAINST 4 funds |
| IVANHOE ELECTRIC INC. | June 5, 2025 | Election of Directors: Sofia Bianchi Director Elections |
Board | For | FOR 3 funds |
AGAINST 4 funds |
| JABIL INC. | January 23, 2025 | Approve (on an advisory basis) Jabil's executive compensation. Say-on-Pay |
Board | For | AGAINST 19 funds |
FOR 17 funds |
| JAMES RIVER GROUP HOLDINGS LTD. | October 24, 2024 | Election of Directors: Dennis J. Langwell Director Elections |
Board | For | FOR 8 funds |
AGAINST 7 funds |
| JAMES RIVER GROUP HOLDINGS LTD. | October 24, 2024 | Election of Directors: Ollie L. Sherman, Jr. Director Elections |
Board | For | FOR 8 funds |
AGAINST 7 funds |
| JAMES RIVER GROUP HOLDINGS LTD. | October 24, 2024 | Election of Directors: Peter B. Migliorato Director Elections |
Board | For | FOR 8 funds |
AGAINST 7 funds |
| JAMES RIVER GROUP HOLDINGS LTD. | October 24, 2024 | Election of Directors: Thomas L. Brown Director Elections |
Board | For | FOR 8 funds |
AGAINST 7 funds |
| JEFFERIES | March 27, 2025 | Advisory vote to approve 2024 executive-compensation program. Say-on-Pay |
Board | Not determined | AGAINST 20 funds |
FOR 14 funds |
| JEFFERIES | March 27, 2025 | Election of Directors: MaryAnne Gilmartin Director Elections |
Board | Not determined | AGAINST 19 funds |
FOR 13 funds |
| JEFFERIES | March 27, 2025 | Election of Directors: Melissa V. Weiler Director Elections |
Board | Not determined | AGAINST 19 funds |
FOR 13 funds |
| JEFFERIES | March 27, 2025 | Election of Directors: Robert D. Beyer Director Elections |
Board | Not determined | AGAINST 19 funds |
FOR 13 funds |
| JELD-WEN HOLDING INC. | April 24, 2025 | To approve the amended and restated 2017 Omnibus Equity Plan. Compensation |
Board | For | AGAINST 20 funds |
FOR 7 funds |
| JOHN B. SANFILIPPO & SON INC. | October 30, 2024 | Election of Directors: Ellen C. Taaffe Director Elections |
Board | For | WITHHOLD 15 funds |
FOR 7 funds |
| JOHNSON & JOHNSON | April 24, 2025 | Election of Directors: Hubert Joly Director Elections |
Board | For | AGAINST 19 funds |
FOR 15 funds |
| JONES LANG LASALLE INC. | May 21, 2025 | Approval, on an advisory basis, of JLL's Executive Compensation ("Say On Pay") Say-on-Pay |
Board | For | AGAINST 25 funds |
FOR 17 funds |
| KALVISTA PHARMACEUTICALS INC. | October 3, 2024 | Approval, on a non-binding advisory basis, of the compensation paid by us to our named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 13 funds |
FOR 3 funds |
| KB HOME | April 17, 2025 | Election of Directors: Arthur R. Collins Director Elections |
Board | For | AGAINST 19 funds |
FOR 10 funds |
| KB HOME | April 17, 2025 | Election of Directors: James C. Weaver Director Elections |
Board | For | AGAINST 19 funds |
FOR 10 funds |
| KB HOME | April 17, 2025 | Election of Directors: Jodeen A. Kozlak Director Elections |
Board | For | AGAINST 19 funds |
FOR 10 funds |
| KB HOME | April 17, 2025 | Election of Directors: Jose M. Barra Director Elections |
Board | For | AGAINST 19 funds |
FOR 10 funds |
| KENNEDY-WILSON HOLDINGS INC. | June 5, 2025 | To approve an amendment to the Company's Second Amended and Restated 2009 Equity Participation Plan to increase the number of shares of the Company's common stock that may be issued thereunder by an additional 3,400,000 shares. Compensation |
Board | For | AGAINST 9 funds |
FOR 8 funds |
| KEROS THERAPEUTICS INC. | June 4, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 3 funds |
| KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | June 3, 2025 | Election of Class I Directors to serve until the 2028 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Sanj K. Patel Director Elections |
Board | For | AGAINST 6 funds |
FOR 2 funds |
| KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | June 3, 2025 | Subject to the passing of Proposal No. 11, to empower the Board of Directors generally pursuant to section 570(1) and section 573 of the Companies Act to allot equity securities (as defined in section 560 of the Companies Act) for cash pursuant to the general authority conferred on them by Proposal No. 11 as if section 561(1) of the Companies Act did not apply to that allotment. This power (a) shall be limited to the allotment of equity securities up to a maximum aggregate of $6,976.33; (b) will expire (unless previously renewed, varied or revoked) on June 2, 2030, but we may at any time before the expiration of this power make an offer or agreement which would or might require equity securities to be allotted after that expiry and the Board of Directors may allot equity securities pursuant to any of those offers or agreements as if the power had not expired; and (c) will apply in relation to a sale of shares which is an allotment of equity securities by virtue of section 560(3) of the Companies Act as if in the first paragraph of this proposal the words "pursuant to the general authority conferred on them by Proposal No. 11" were omitted. For purposes of this resolution, references to the allotment of equity securities shall be interpreted in accordance with section 560 of the Companies Act. This resolution replaces all unexercised powers previously granted to the Board of Directors, pursuant to the adoption of the Articles in June 2024, to allot equity securities as if section 561 of the Companies Act did not apply but shall be without prejudice to any allotment of equity securities already made or agreed or agreed to be made pursuant to such authorities. Capital Structure |
Board | For | AGAINST 6 funds |
FOR 2 funds |
| KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | June 3, 2025 | To authorize the Board of Directors, generally and unconditionally for the purpose of section 551 of the UK Companies Act 2006 (the "Companies Act") to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the company ("Rights") up to a maximum aggregate nominal amount of $6,976.33, which represents approximately 35% of the issued ordinary share capital of the Company on the record date for the 2025 Annual General Meeting of Shareholders. This authority shall expire (unless previously renewed, varied or revoked) on June 2, 2030, but we may at any time before the expiration of this authority make an offer or agreement which would or might require shares to be allotted, or Rights to be granted, pursuant to this authority after its expiration, and the Board of Directors may allot shares or grant Rights in pursuance of that offer or agreement as if the authority conferred by this resolution had not expired. The authority granted by this resolution shall replace all of our existing authorities to allot any shares and to grant Rights previously granted in connection with the adoption of the Articles in June 2024, but without prejudice to any allotment of shares or grant of Rights already made or agreed or offered to be made pursuant to such authorities. Capital Structure |
Board | For | AGAINST 6 funds |
FOR 2 funds |
| KLAVIYO INC. | June 10, 2025 | To elect three Class II directors to serve until the 2028 annual meeting of stockholders or until their successors are duly elected and qualified: Ed Hallen Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 3 funds |
| KLX ENERGY SERVICES HOLDINGS INC. | May 7, 2025 | To approve, on an advisory, non-binding basis, the compensation of the Company's named executive officers; Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 2 funds |
| KODIAK GAS | April 23, 2025 | Election of three nominees: Alex N. Darden Director Elections |
Board | Not determined | WITHHOLD 21 funds |
FOR 4 funds |
| KODIAK SCIENCES INC. | June 2, 2025 | Approve, on an advisory basis, the compensation of Kodiak's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 5 funds |
| KOHL'S CORP. | May 14, 2025 | To approve, by an advisory vote, the compensation of our Named Executive Officers. Say-on-Pay |
Board | For | AGAINST 17 funds |
FOR 9 funds |
| KOPPERS HOLDINGS INC. | May 8, 2025 | PROPOSAL TO APPROVE OUR AMENDED AND RESTATED 2020 LONG TERM INCENTIVE PLAN Compensation |
Board | For | AGAINST 20 funds |
FOR 7 funds |
| KORU MEDICAL SYSTEMS INC. | May 14, 2025 | Approval, on an advisory basis, of the compensation of the Company's executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 2 funds |
| KRONOS WORLDWIDE INC. | May 14, 2025 | Director Nominees: James M. Buch Director Elections |
Board | For | WITHHOLD 17 funds |
FOR 4 funds |
| KRONOS WORLDWIDE INC. | May 14, 2025 | Director Nominees: John E. Harper Director Elections |
Board | For | WITHHOLD 17 funds |
FOR 4 funds |
| KRONOS WORLDWIDE INC. | May 14, 2025 | Director Nominees: Loretta J. Feehan Director Elections |
Board | For | WITHHOLD 17 funds |
FOR 4 funds |
| KRONOS WORLDWIDE INC. | May 14, 2025 | Director Nominees: Michael S. Simmons Director Elections |
Board | For | WITHHOLD 17 funds |
FOR 4 funds |
| KRONOS WORLDWIDE INC. | May 14, 2025 | Director Nominees: R. Gerald Turner Director Elections |
Board | For | WITHHOLD 17 funds |
FOR 4 funds |
| KRONOS WORLDWIDE INC. | May 14, 2025 | Nonbinding advisory vote approving named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 18 funds |
FOR 5 funds |
| KURA ONCOLOGY INC. | June 5, 2025 | Approval of an amendment to our Amended and Restated 2014 Equity Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 4 funds |
| KURA SUSHI USA INC. | January 23, 2025 | Election of Directors: Shintaro Asako Director Elections |
Board | For | AGAINST 10 funds |
FOR 4 funds |
| KYMERA THERAPEUTICS INC. | June 25, 2025 | To approve, on a non-binding advisory basis, the compensation of our named executive officers; and Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 5 funds |
| L3HARRIS T | April 18, 2025 | Approval, in an Advisory Vote, of the Compensation of Named Executive Officers as Disclosed in the Proxy Statement. Say-on-Pay |
Board | Not determined | AGAINST 17 funds |
FOR 15 funds |
| LABCORP HO | May 15, 2025 | Election of the members of the Company's Board of Directors: Peter M. Neupert Director Elections |
Board | Not determined | AGAINST 17 funds |
FOR 14 funds |
| LAKELAND FINANCIAL CORP. | April 8, 2025 | ELECTION OF DIRECTORS: Bradley J. Toothaker Director Elections |
Board | For | FOR 16 funds |
WITHHOLD 8 funds |
| LANDMARK BANCORP INC. | May 21, 2025 | Election of Directors: Patrick L. Alexander Director Elections |
Board | For | AGAINST 19 funds |
FOR 1 fund |
| LANTHEUS HOLDINGS INC. | May 1, 2025 | The election of four Class I directors to our Board of Directors: Dr. Gerard Ber Director Elections |
Board | For | AGAINST 13 funds |
FOR 8 funds |
| LANTHEUS HOLDINGS INC. | May 1, 2025 | The election of four Class I directors to our Board of Directors: Mr. Samuel Leno Director Elections |
Board | For | AGAINST 13 funds |
FOR 8 funds |
| LANTHEUS HOLDINGS INC. | May 1, 2025 | The election of four Class I directors to our Board of Directors: Ms. Mary Anne Heino Director Elections |
Board | For | AGAINST 13 funds |
FOR 8 funds |
| LANTRONIX INC. | November 5, 2024 | To approve an amendment to our 2020 Performance Incentive Plan to increase the number of shares of common stock reserved for issuance under the plan by 1,800,000 shares. Compensation |
Board | For | FOR 18 funds |
AGAINST 1 fund |
| LANTRONIX INC. | November 5, 2024 | To approve, on a non-binding advisory basis, the compensation paid to our named executive officers as described in the proxy statement accompanying this notice. Say-on-Pay |
Board | For | AGAINST 19 funds |
FOR 2 funds |
| LEGACY HOUSING CORP. | December 4, 2024 | Election of Directors: Curtis D. Hodgson Director Elections |
Board | For | FOR 20 funds |
AGAINST 4 funds |
| LEGALZOOM.COM INC. | June 3, 2025 | Election of Directors: Neil Tolaney Director Elections |
Board | For | WITHHOLD 4 funds |
FOR 5 funds |
| LEMAITRE VASCULAR INC. | June 2, 2025 | Election of Directors: David B. Roberts Director Elections |
Board | For | WITHHOLD 7 funds |
FOR 4 funds |
| LEMAITRE VASCULAR INC. | June 2, 2025 | Election of Directors: George W. LeMaitre Director Elections |
Board | For | WITHHOLD 7 funds |
FOR 4 funds |
| LEMAITRE VASCULAR INC. | June 2, 2025 | Election of Directors: Martha Shadan Director Elections |
Board | For | WITHHOLD 7 funds |
FOR 4 funds |
← Previous Page 7 of 14 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 18, 2026 from SEC Form N-PX filings.